Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BDX - BECTON DICKINSON & CO


Close
228.285
-0.895   -0.392%

Share volume: 39,253
Last Updated: Fri 27 Dec 2024 08:30:01 PM CET
Surgical and Medical Instrument Manufacturing : -0.06%

PREVIOUS CLOSE
CHG
CHG%

$229.18
-0.90
-0.39%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
37%
Profitability 30%
Dept financing 50%
Liquidity 12%
Performance 46%
Company vs Stock growth
vs
Performance
5 Days
0.74%
1 Month
2.77%
3 Months
-5.54%
6 Months
-1.22%
1 Year
-5.93%
2 Year
-10.65%
Key data
Stock price
$228.28
P/E Ratio 
49.59
DAY RANGE
$226.65 - $230.04
EPS 
$4.84
52 WEEK RANGE
$222.08 - $249.89
52 WEEK CHANGE
-$6.44
MARKET CAP 
70.067 B
YIELD 
1.54%
SHARES OUTSTANDING 
289.042 M
DIVIDEND
$0.95
EX-DIVIDEND DATE
06/10/2024
NEXT EARNINGS DATE
11/07/2024
BETA 
0.42
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,171,093
AVERAGE 30 VOLUME 
$2,270,700
Company detail
CEO: Thomas E. Polen
Region: US
Website: bd.com
Employees: 77,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis cathetters, vascular care and preparation products, needle-free IV connectors and extensions sets, syringes, pen needles, and other products for diabetes. Its Life Sciences segment provides specimen and blood collection products; other surgical products.

Recent news